Bank of Montreal’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Bank of Montreal’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-566	Closed	–	–	4974
2018 Q1	$0	Hold	566	–	–	﹤0.01%	4476
2017 Q4	$1K	Sell	566 -268	-32%	-$461	﹤0.01%	4138
2017 Q3	$1K	Hold	834	–	–	﹤0.01%	4129
2017 Q2	$1K	Buy	834 +394	+90%	+$883	﹤0.01%	4117
2017 Q1	$2K	Hold	440	–	–	﹤0.01%	3861
2016 Q4	$5K	Hold	440	–	–	﹤0.01%	3764
2016 Q3	$11K	Hold	440	–	–	﹤0.01%	3539
2016 Q2	$11K	Hold	440	–	–	﹤0.01%	3570
2016 Q1	$13K	Buy	440 +172	+64%	+$4.67K	﹤0.01%	3543
2015 Q4	$10K	Buy	+268	New	+$11.8K	﹤0.01%	3628

Other funds holding ANTH

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Bank of Montreal's ANTH Position: Q2 2018 in Review

Bank of Montreal sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2018, closing a stake of 566 shares.

Bank of Montreal first reported a position in ANTH in Q4 2015 and held it in 10 quarters. The position peaked at $13K in Q1 2016. 5 funds tracked by Wall St. Rank hold ANTH as of Q2 2018.

Bank of Montreal reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Bank of Montreal sold 566 Anthera Pharmaceuticals, Inc. shares in Q2 2018.
Bank of Montreal first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2015 and held it in 10 quarters.
Bank of Montreal's Anthera Pharmaceuticals, Inc. position peaked at $13K in Q1 2016.
5 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2018.

Based on Bank of Montreal's 13F filing for Q2 2018, filed 16 Jul 2018.